Mesenkia Therapeutics (private company)
See something wrong or missing? Let us know
Offices:Uppsala
Industry:BiotechHealth services
Business model:B2B
Mesenkia Therapeutics AB is a pharma company in Sweden developing a new drug for patients with glioblastoma
Investors:
we tracked 2 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 579.6k
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Mesenkia Therapeutics
Name | Criteria | |
---|---|---|
![]() |
Aquilón CyL
47%
|
|
![]() |
Cornea Project
47%
|
|
![]() |
Ikan Biotech
47%
|
|
![]() |
In Singulo Solutions AB
47%
|
|
![]() |
Merozyne Therapeutics
47%
|
|
![]() |
Polimerbio
47%
|
|
![]() |
Synartro
47%
|
|
![]() |
VOC Diagnostics
47%
|
|
![]() |
ZeCardio Therapeutics
47%
|
|
![]() |
Kilobaser
47%
|
|